已收盘 02-06 16:00:00 美东时间
-0.020
-1.98%
Results demonstrated a favorable safety profile, with no device- or procedure-related major adverse events measured at both seven and 30 days, and strong acute and chronic performance. Among 14 patients with inducible VT
02-04 21:10
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 9.3% to $...
2025-12-24 05:05
Shares of B Riley Financial Inc (NASDAQ:RILY) rose sharply in pre-market tradin...
2025-12-16 18:53
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Lake Street analyst Frank Takkinen initiates coverage on Adagio Medical Holdings (NASDAQ:ADGM) with a Buy rating and announces Price Target of $4.
2025-12-02 22:54
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.66) per share. This is a 3400 percent decrease over earnings of $0.02 per share from the same period last year.
2025-11-13 05:37
LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or the "Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today
2025-10-15 20:07
97% Acute Effectiveness and Favorable Safety Results from Proprietary ULTC for Ventricular TachycardiaAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation
2025-10-11 03:43
Gainers Check-Cap (NASDAQ:CHEK) stock increased by 353.1% to $3.38 during Mond...
2025-09-15 20:10
Gainers Biodesix (NASDAQ:BDSX) shares increased by 21.6% to $0.52 during Wedne...
2025-09-04 05:06